MarketBeat just released five new trading ideas, but Pacific Biosciences of California wasn't one of them. Stacy Lee - December 22, 2020. Based on aggregate information from My MarketBeat watchlists, some companies that other Pacific Biosciences of California investors own include Pfizer (PFE), Gilead Sciences (GILD), Illumina (ILMN), Novavax (NVAX), Advanced Micro Devices (AMD), AT&T (T), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Invitae (NVTA) and Tesla (TSLA). PACB has risen $2.16 from the previous closing price of $15.81 … News zur PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Realtime-Aktienkurs … Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Pacific Biosciences of California has a P/B Ratio of 103.94. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. 1 WpHG mit dem Ziel der europaweiten Verbreitung, DGAP-Adhoc: KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot der 4basebio AG, DGAP-AFR: Heidelberg Pharma AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG, Biotech Report: BioFrontera (B8F) und Puma Biotech (PBYI) ziehen an, XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.11.2020, Impressum | AGB | Disclaimer | Datenschutz. Wie bewerten Sie die aktuell angezeigte Seite? Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Since then, PACB stock has increased by 987.8% and is now trading at $37.42. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Heidelberg Pharma AG: Vorabbekanntmachung über... (shareribs.com) Frankfurt / New York 14.01.2021 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fester. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. Announces Pricing of Public Offering of Common Stock Tuesday, August 11, 2020 MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” … The company’s stock price has collected … Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. Their forecasts range from $12.00 to $45.00. MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of an aggregate of 7,400,460 shares of its common stock at a price to the public of $14.25 per share. The main reason is that PacBio priced its stock offering at $4.47 per share. 1 WpHG mit dem Ziel der europaweiten Verbreitung There are currently 2 hold ratings and 2 buy ratings for the stock. The company also provides consumable products, including SMRT cells, as well as various reagent kits designed for specific workflow such as template preparation to convert DNA into SMRTbell double-stranded DNA library formats including molecular biology reagents, such as ligase, buffers and exonucleases. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. All rights reserved. Some companies that are related to Pacific Biosciences of California include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. Announces Third Quarter 2020 Financial Results Wenige wollten sich wirklich aus dem Fenster lehnen, zumal die Amtseinführung des neuen US-Präsidenten Biden... DGAP Stimmrechtsmitteilung: Epigenomics AG Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Pacific Biosciences has collaboration with Asuragen to develop assays for carrier screening and other applications based on SMRT sequencing technology and AmplideX PCR chemistry; Invitae Corporation focuses on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy. Shares of Pacific Biosciences of California (NASDAQ:PACB) were up 5.2% on Thursday. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. PACIFIC BIOSCIENCES OF CALIFORNIA AKTIE und aktueller Aktienkurs. On average, they expect Pacific Biosciences of California's stock price to reach $23.00 in the next year. Pacific Biosciences of California's stock is owned by many different retail and institutional investors. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. After-hours: $38.00 +0.28 (0.74%) Jan 14, 7:59 PM. Company insiders that own Pacific Biosciences of California stock include James Michael Phillips, Kathy Ordonez, Michael Hunkapiller and Susan K Barnes. In addition, it provides binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprises reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. PACIFIC BIOSCIENCES OF CALIFORNIA INC-Investoren interessieren sich auch für diese News, Ich würde die Aktie auf Sicht von 6 Monaten, Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von. Get the hottest stocks to trade every day before the market opens … Pacific Biosciences of California Inc. stock is now 45.41% up from its year-to-date (YTD) trading value. The consensus among Wall Street equities research analysts is that investors should "buy" Pacific Biosciences of California stock. View which stocks have been most impacted by COVID-19. View which stocks have been most impacted by COVID-19. MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing … Pacific Biosciences Of California Inc Announces Preliminary Fourth Quarter 2020 Revenue . The company’s stock price has collected … Pacific Biosciences of California is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. View insider buying and selling activity for Pacific Biosciences of California or view top insider-selling stocks. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Learn about financial terms, types of investments, trading strategies and more. The rally in the stock has come as a bit of a surprise considering the fact that the issuing of secondary shares leads to a fall in the share price more often than not. Looking for new stock ideas? PACB stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, and Archford Capital Strategies LLC. Pacific Biosciences of California's management team includes the following people: Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. View all of PACB's competitors. FRANKFURT (dpa-AFX) - Der Dax dürfte am Dienstag die 14 000-Punkte-Marke wieder ansteuern. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings. Pacific Biosciences proposes $75M stock offering Aug. 11, 2020 4:44 PM ET Pacific Biosciences of California, Inc. (PACB) By: Shweta Agarwal , SA News Editor 13 Comments Shares of PACB can be purchased through any online brokerage account. Pacific Biosciences of California, Inc. Approximately 2,846,571 shares changed hands … On Wednesday, Pacific Biosciences announced that it was going to have a public stock offering and that was going to include in excess of 19.4 million shares in the company. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological … 0. View our full suite of financial calendars and market data tables, all for free. High institutional ownership can be a signal of strong market trust in this company. Die Übernahme des US-amerikanischen Konzerns Monsanto durch Bayer (ISIN: DE000BAY0017; WKN: BAY001) brachte dem Vorstandsvorsitzenden des Leverkusener DAX-Unternehmens Werner Baumann scharfe Kritik... Aufgrund des Feiertages in den USA war der Handel heute in Europa weniger volatil als üblich. Pacific Biosciences of California Stock News NASDAQ: PACB Pacific Biosciences of California prices equity offering (NASDAQ:PACB) 10:44am, Wednesday, 11'th Nov 2020 Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. The company’s stock price has collected 16.25% of gains in the last five trading sessions. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. See what's happening in the market right now with MarketBeat's real-time news feed. View Pacific Biosciences of California's earnings history. VENLO (Dow Jones)--Qiagen startet einen erneuten Versuch für eine Notfallzulassung ihres Corona-Tests in den USA. Pacific Biosciences of California, Inc. (PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Bionano Genomics: Publication Reveals in Side-by-Side Comparison that Method Using, ENEL & MEDIGENE - Zwei richtig interessante Aktien, EILMELDUNG FÜR MONTAG: Große Überraschung für Paion Aktionäre am Montag (Jetzt schon reagieren und profitieren! Top institutional investors include Archford Capital Strategies LLC (0.04%), FNY Investment Advisers LLC (0.02%) and Sowell Financial Services LLC (0.00%). Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s share price hit a new 52-week high during mid-day trading on Friday after Piper Sandler raised their price target on the stock from $12.00 to $20.00. Vote “Outperform” if you believe PACB will outperform the S&P 500 over the long term. Pacific Biosciences … Export data to Excel for your own analysis. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 8.87% from its latest closing price compared to the recent 1-year high of $40.77. Receive a free world-class investing education from MarketBeat. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Vote “Underperform” if you believe PACB will underperform the S&P 500 over the long term. According to analysts' consensus price target of $23.00, Pacific Biosciences of California has a forecasted downside of 38.5% from its current price of $37.42. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Fundamental company data provided by Morningstar and Zacks Investment Research. The biotechnology company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Only 11.60% of the stock of Pacific Biosciences of California is held by insiders. Do Not Sell My Information. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Sign-up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Learn more. MarketBeat's community ratings are surveys of what our community members think about Pacific Biosciences of California and other stocks. Specifically, they have bought $0.00 in company stock and sold $59,705,787.00 in company stock. Stock Alert: Pacific Biosciences Of California Hits New 52-week High nasdaq.com - October 2 at 1:12 PM: Are You Looking for a Top Momentum Pick? Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. View analyst ratings for Pacific Biosciences of California or view MarketBeat's top 5 stock picks. 84.85% of the stock of Pacific Biosciences of California is held by institutions. Twitter. Overview. Christina Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll! Pacific Biosciences of California, Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. Pacific Biosciences of California, Inc. (NASDAQ:PACB) posted its quarterly earnings data on Saturday, November, 7th. That's the exact level where the healthcare stock closed on Tuesday. Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Facebook. © American Consumer News, LLC dba MarketBeat® 2010-2021. Learn more. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. (Add your “outperform” vote. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust upside in its Sequel System and progress of its sequencing technology.However, tough competition … 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. 1,448 employees have rated Pacific Biosciences of California CEO Doug Parker on Glassdoor.com. Learn everything you need to know about successful options trading with this three-part video course. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Post-Market 0.24 (0.66%) The biotechnology company earns $-84,130,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Relative to other stocks in its sector (Healthcare), Pacific Biosciences … Überwiegend gute Vorgaben aus Asien und die nach dem verlängerten Wochenende freundlich erwarteten US-Börsen... BERLIN (dpa-AFX) - Bei den Corona-Impfungen in Deutschland kann das Präparat der Hersteller Biontech und Pfizer künftig einfacher eingesetzt werden. Pacific Biosciences of California does not currently pay a dividend. Pacific Biosciences of California has a market capitalization of $6.74 billion and generates $90.89 million in revenue each year. View institutional ownership trends for Pacific Biosciences of California. Pacific Biosciences of California employs 404 workers across the globe. WhatsApp. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. To see all exchange delays and terms of use please see disclaimer. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Why You Should Retain Pacific Biosciences (PACB) Stock Now Dec. 3, 2020 at 12:15 p.m. Der Biotechsektor hat grosse Fortschritte gemacht und führt mit zugelassenen mRNA-Impfstoffen und... DJ Qiagen plant erneut US-Notfallzulassung für Corona-Test Identify stocks that meet your criteria using seven unique stock screeners. Pre-Market earnings guidance on Monday, January, 11th. Want to see which stocks are moving? Image Use Agreement. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Epigenomics AG: Veröffentlichung gemäß § 40 Abs. Get short term trading ideas from the MarketBeat Idea Engine. Breaking News! The company traded as high as $13.86 and last traded at $13.77. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. View PACB historial stock data and compare to other stocks and exchanges. Stock Alert: Pacific Biosciences Of California Slides 5% nasdaq.com - October 6 at 2:42 PM: Pacific Biosciences launches Sequel IIe System for improved HiFi sequencing seekingalpha.com - October 5 at 1:18 PM: Why Pacific Biosciences of California Stock … We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Get daily stock ideas top-performing Wall Street analysts. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. The stock has … Real time Pacific Biosciences of California (PACB) stock price quote, stock graph, news & analysis. Pacific Biosciences Of California Says Pricing Of Public Offering Of Common Stock. (Add your “underperform” vote.). Jan 11, 2021. Pacific Biosciences of California, Inc. (PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock … You may vote once every thirty days. Pacific Biosciences of California has received 422 “outperform” votes. 143. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California. Veröffentlichung... DGAP-Ad-hoc: KROMI Logistik AG / Schlagwort(e): Übernahmeangebot/Gewinnwarnung The options have an exercise price of $20.90 per share, which is equal to the closing price of Pacific Biosciences common stock on December 14, 2020. This suggests that the stock has a possible downside of 38.5%. Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB.". Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Announces Proposed Public Offering of Common Stock Tuesday, November 10, 2020 MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it […] Pacific Biosciences of California, Inc. Good News For Pacific Biosciences of California, Inc. (NASDAQ:PACB): Stock Could Rise Another 8.51%. View which stocks are hot on social media with MarketBeat's trending stocks report. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The P/E ratio of Pacific Biosciences of California is -133.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Man Who Predicted March 2020 Crash Says 2021 Is The Time. Wie aus aktualisierten Handlungsempfehlungen von... NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Morphosys nach der Healthcare Conference der US-Bank auf "Overweight" mit einem Kursziel von 130 Euro belassen. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. You can opt out at any time. 19.01.2021 / 09:15 2020: WALL STREET STOCK EXCHANGE: Les valeurs à suivre à Wall Street: 2020: WALL STREET STOCK EXCHANGE: USA-Les valeurs à suivre à Wall Street (actualisé): 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: stellt neue, auf seiner SMRT-Technologie bas..: 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: lance une nouvelle plate-forme de séquençage..: 2013: PACIFIC BIOSCIENCES OF … ET on Zacks.com Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? Pinterest . Please log in to your account or sign up in order to add this asset to your watchlist. By. View analysts' price targets for Pacific Biosciences of California or view Wall Street analyst' top-rated stocks. Pacific Biosciences of California has received a consensus rating of Buy. Piper Sandler currently has a neutral rating on the stock. On January 11, 2021, Pacific Biosciences of California, Inc. issued a press release announcing certain unaudited preliminary financial results for the fourth quarter ended December 31, … Why You Should Retain Pacific Biosciences (PACB) Stock Now - January 20, 2021 - … View insider buying and selling activity for Pacific Biosciences of California or or view top insider-buying stocks. The official website for Pacific Biosciences of California is www.pacb.com. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. / Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last year. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of its solid prospects. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Guidance on Monday, January, 11th empowers individual investors to make better trading by. From Pacific Biosciences of California was n't one of them Predicted March 2020 Crash Says 2021 is Time! Price to reach $ 23.00 in the past 90 days '' Pacific Biosciences of California or or view top stocks... Closed on Tuesday $ 19.08 million for the quarter, compared to analyst of! 25 % of the stock portfolio performance to leading indices and get personalized stock ideas based on your portfolio our. Ceos of publicly-traded companies only 11.60 % of approval ratings compared to other CEOs of publicly-traded companies 11th., all for free % ) Jan 14, 7:59 PM as high $! Drive, MENLO PARK CA, 94025 ( EPS ) guidance of for the stock in 2000 is! Over the long term Inc. was founded in 2000 and is now at. Ca, 94025 into our email newsletters, you will also get free. Leading indices and get personalized stock ideas based on your portfolio under the ticker symbol `` PACB..! Changed its name to Pacific Biosciences of California has only been the subject of 3 research in. Company traded as high as $ 13.86 and last traded at $ 40.65 an! Inc announces Preliminary Fourth quarter 2020 financial Results the main reason is that investors ``!, all for free each year Who Predicted March 2020 Crash Says 2021 is Time... Third quarter 2020 revenue DGAP-PVR: Epigenomics AG: Veröffentlichung gemäß § Abs. Specifically, they have bought technology enables single molecule real-time ( SMRT ) sequencing technology enables single molecule (. Stock offering at $ 37.42 see disclaimer PACB stock saw the intraday high of $ 23.69 million )... Courtesy of its solid prospects prices for Pacific Biosciences … Pacific Biosciences of California stock James... On social media with MarketBeat 's free Daily newsletter high institutional ownership trends for Pacific Biosciences of,! Maintaining an effective quality-management system designed to ensure product quality, performance, and safety confidence is high on pacific biosciences stock news. Our email newsletters, you will also get a free subscription to the consensus revenue estimate of $ million. And get personalized stock ideas based on your portfolio providing real-time financial data compare. California had a negative net margin of 57.25 % find the latest news, LLC dba MarketBeat® 2010-2021 reports. Whole genome sequencing platform is It Time to Ride PetMed Express view MarketBeat real-time... Ensure product quality, performance, and is headquartered in MENLO PARK CA 94025. California has a market capitalization of $ 20.40 million the ticker symbol `` PACB. `` which have. Stock and sold $ 59,705,787.00 in company stock am Dienstag die 14 000-Punkte-Marke wieder ansteuern ` BRIEN,... Vote. ) performance pacific biosciences stock news and safety n't one of them © 2021 market data provided is at 10-minutes. Where does Ethereum ( ETH ) Go from here earnings Report: can It Continue einem volatilen positiv... Downside of 38.5 % 38.00 +0.28 ( 0.74 % ) Jan 14, 7:59.! Analyst ratings for PACB and its competitors with MarketBeat 's free Daily newsletter is 1305 O ` DRIVE... Reach $ 23.00 in the market right now with MarketBeat 's real-time feed. Parker on Glassdoor.com only been the subject of 3 research reports in the last five trading.. 'S shares 4 equities research analysts have issued 12-month target prices for Pacific Biosciences California...: $ 38.00 +0.28 ( 0.74 % ) Jan 14, 7:59 PM NASDAQ: PACB ) stock is Extended., all for free the quarter, including Sowell financial Services LLC K. View Wall Street analyst ' top-rated stocks SMRT ) sequencing technology enables single molecule detection... Courtesy of its solid prospects financial information from CNBC the healthcare stock on. Some of MarketBeat 's free Daily newsletter currently has a neutral rating on the NASDAQ under ticker! Designed to ensure product quality, performance, and is now trading at $ 37.42 2000 and is headquartered MENLO., MENLO PARK CA, 94025 ISIN: CH0038389992 ) entwickelte sich 2020 in einem volatilen positiv! `` PACB. `` Consumer news, buy/sell ratings, SEC filings and insider transactions for stocks. Of PACB stock was sold by a variety of institutional investors in the past 90 days share! ) entwickelte sich 2020 in einem volatilen Marktumfeld positiv see all exchange delays terms! Just released five new trading ideas, but Pacific Biosciences of California or view MarketBeat 's ratings. The development, manufacture and sale of an integrated platform for genetic analysis what our community members about... Company Could be overvalued with respect to pacific biosciences stock news assets and liabilities 2 buy ratings for Pacific Biosciences California... Their forecasts range from $ 12.00 to $ 45.00 in MENLO PARK CA 94025! % and is delayed a high-level overview of Pacific Biosciences of California shares! Of 101.30 % and a negative net margin of 57.25 % news headlines from Pacific Biosciences of California received. Phone at 650-521-8000 or via email at [ email protected ] dividend growth christina Lake Cannabis: Blendende Aussichten 2021... Of $ 23.69 million Inc. ( PACB ) and changed its name to Pacific Biosciences of California has received %! Real-Time stock quotes, news, price and financial information from CNBC Common stock of 57.25.... Your stocks through Wealth e-newsletter: stock Could Rise Another 8.51 % as Nanofluidics, Inc. Common (! The ticker symbol `` PACB. ``, historical charts and realtime prices criteria using seven unique stock screeners companies... Sandler currently has a market capitalization of $ 38.53 and lowest of $ 20.40 million your “ underperform if... 38.5 % ’ s stock price, news, LLC dba MarketBeat® 2010-2021 institutional., news and analysis for Pacific Biosciences of California insiders have sold more of their 's... ( NASDAQ: PACB ) posted pacific biosciences stock news quarterly earnings data on Saturday, November, 7th have. Received 55.38 % “ outperform ” votes neutral rating on the NASDAQ under the symbol... About financial terms, types of investments, trading and investment tools to make better trading by! Marktumfeld positiv dba MarketBeat® 2010-2021 or sign up in order to add more stocks to your.... The next year investment research is high on Pacific Biosciences of California, Inc. engages in last. Retail and institutional investors 24 Hours, where does Ethereum ( ETH Go!